Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Medox is a brand of nutritional supplements manufactured by CAPS Holdings, the largest pharmaceutical company in Zimbabwe. The Medox product line includes several formulations designed to address vitamin and mineral deficiencies and support general health. The flagship product, **Medox 12+12**, is a comprehensive multivitamin and multimineral supplement containing 12 essential vitamins (including A, B-complex, C, D, E, and K) and 12 minerals (such as iron, calcium, and zinc). Another prominent product is **Medox C Forte**, which provides a high dose of Vitamin C (500 mg of ascorbic acid) in a chewable tablet format. Historically, the brand has also included specific formulations like Medox BCO (Vitamin B Complex) and Medox Vitamin A tablets. These products are marketed as over-the-counter (OTC) medicines and are widely used in Zimbabwe and the surrounding region for the prevention and treatment of nutritional deficiencies.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Medox.